Prolonged neonatal parathyroid suppression. A sequel to asymptomatic maternal hyperparathyroidism.
D000236:Adenoma / Q000150:complications / Q000601:surgery; D000284:Administration, Oral; D000536:Aluminum Hydroxide / Q000627:therapeutic use; D002118:Calcium / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006961:Hyperparathyroidism / Q000175:diagnosis / Q000209:etiology; D006996:Hypocalcemia / Q000209:etiology; D007011:Hypoparathyroidism / Q000151:congenital* / Q000188:drug therapy; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases; D008274:Magnesium / Q000097:blood / Q000627:therapeutic use; D008431:Maternal-Fetal Exchange; D010282:Parathyroid Neoplasms / Q000150:complications / Q000601:surgery; D010710:Phosphates / Q000097:blood; D011247:Pregnancy; D011248:Pregnancy Complications; D012640:Seizures / Q000209:etiology
D010710:Phosphates; D000536:Aluminum Hydroxide; D008274:Magnesium; D002118:Calcium